Transcutaneous Acupoint Electrical Stimulation on Chemotherapy-Induced Constipation for Non-Small Cell Lung Cancer Patients: A Randomized Controlled Trial

• Автори: Ting Mao (Автор), Xiangyu Liu (Автор), Qinqin Cheng (Автор), Yongyi Chen (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2021-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.
• Notes: 2347-5625; 2349-6673; 10.4103/2347-5625.311129
• Keywords: chemotherapy-induced constipation; non-small cell lung cancer patients; transcutaneous acupoint electrical stimulation; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282; Nursing; RT1-120
• Source: Asia-Pacific Journal of Oncology Nursing, Vol 8, Iss 4, Pp 385-392 (2021)

Objective: Chemotherapy-induced constipation (CIC) adversely affects the quality of life of non-small cell lung cancer (NSCLC) patients. This study aimed to investigate the clinical effects of transcutaneous acupoint electrical stimulation (TAES) on CIC. Methods: Sixty NSCLC patients who received chemotherapy at Hunan Cancer Hospital, Changsha, China, were assigned to the TAES (n = 30) or control (n = 30) group using Research Randomizer. In the TAES group, four acupoints, namely Tianshu, Quchi, Zusanli, and Shangjuxu, were stimulated six times a week, lasting for 4 weeks, while the control group received the usual care. The Bristol Stool Form Scale (BSFS) and the Constipation Assessment Scale (CAS) were used. Results: Both the BSFS and CAS scores for the experimental group were significantly higher than that for the control group (P = 0.004 and P < 0.001 separately). Conclusions: TAES was effective for alleviating constipation in NSCLC patients receiving chemotherapy and was a safe and practical nursing intervention.